The bone morphogenetic protein antagonist gremlin I is overexpressed in human cancers and interacts with YWHAH protein

BMC Cancer

Volumn 6, Issue , 2006, Pages

  Namkoong, Hong ^a   Shin, Seung Min ^a   Kim, Hyun Kee ^a   Ha, Seon Ah ^a   Cho, Goang Won ^a   Hur, Soo Young ^a   Kim, Tae Eung ^a   Kim, Jin Woo ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; GREMLIN 1; ONCOPROTEIN; PROTEIN 14 3 3; PROTEIN YWHAH; TRYPTOPHAN HYDROXYLASE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CANCER CELL CULTURE; CARCINOGENESIS; CONTROLLED STUDY; DIFFERENTIAL DISPLAY; EMBRYO; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TWO HYBRID SYSTEM; UTERINE CERVIX CANCER; WESTERN BLOTTING;

14-3-3 PROTEINS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL LINE; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTATHIONE TRANSFERASE; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TELOMERASE; TISSUE DISTRIBUTION; TRANSFECTION; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 33646565011     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-6-74     Document Type: Article

References (47)

1. Weinberg RA: Oncogenes and tumor suppressor genes. CA Cancer J Clin 1994, 44:160-170.
2. Bishop JM: Molecular themes in oncogenesis. Cell 1991, 64:235-248.
3. Cooper GM: Oncogenes Boston: Jones and Bartlett Publishers; 1995.
4. Crook T, Wrede D, Tidy JA, Mason WP, Evans DJ, Vousden KH: Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumours. Lancet 1992, 339:1070-1073.
5. Busby-Earle RMC, Steel CM, Williams ARW, Cohen B, Bird CC: p53 mutations in cervical carcinogenesis - low frequency and lack of correlation with human papillomavirus status. Br J Cancer 1994, 69:732-737.
6. Topol LZ, Marx M, Laugier D, Bogdanova NN, Boubnov NV, Clausen PA, Calothy G, Blair DG: Identification of drm, a novel gene whose expression is suppressed in transformed cells and which can inhibit growth of normal but not transformed cells in culture. Mol Cell Biol 1997, 17:4801-4810.
7. Topol LZ, Bardot B, Zhang Q, Resau J, Huillard E, Marx M, Calothy G, Blair DG: Biosynthesis, post-translation modification, and functional characterization of Drm/Gremlin. J Biol Chem 2000, 275:8785-8793.
8. Pearce JJ, Penny G, Rossant J: A mouse cerberus/Dan-related gene family. Dev Biol 1999, 209:98-110.
9. Isaacs NW: Cystine knots. Curr Opin Struct Biol 1995, 5:391-395.
10. Capdevila J, Tsukui T, Rodriquez Esteban C, Zappavigna V, Izpisua Belmonte JC: Control of vertebrate limb outgrowth by the proximal factor Meis2 and distal antagonism of BMPs by Gremlin. Mol Cell 1999, 4:839-849.
11. Dionne MS, Skarnes WC, Harland RM: Mutation and analysis of Dan, the founding member of the Dan family of transforming growth factor β antagonists. Mol Cell Biol 2001, 21:636-643.
12. Khokha MK, Hsu DR, Brunet LJ, Dionne MS, Harland RM: Gremlin is the BMP antagonist required for maintenance of Shh and Fgf signals during limb patterning. Nat Genet 2003, 34:303-307.
13. Zuniga A, Haramis AP, McMahon AP, Zeller R: Signal relay by BMP antagonism controls the SHH/FGF4 feedback loop in vertebrate limb buds. Nature 1999, 401:598-602.
14. Clp1 via a novel mechanism and inhibits neoplastic transformation. Biochem Biophys Res Commun 2002, 295:1135-1141.
15. HanaoKa E, Ozaki T, Nakamura Y, Moriya H, Nakagawara A, Sakiyama S: Overexpression of Dan causes a growth suppression in p53-deficlent SAOS-2 cells. Biochem Biophys Res Commun 2000, 278:20-26.
16. Lappin DW, Hensey C, McMahon R, Godson C, Brady HR: Gremlins, glomeruli and diabetic nephropathy. Curr Opin Nephrol Hypertens 2000, 9:469-472.
17. Michos O, Panman L, Vintersten K, Beier K, Zeller R, Zuniga A: Gremlin-mediated BMP antagonism induces the epithelialmesenchymal feedback signaling controlling metanephric kidney and limb organogenesis. Development 2004, 131(14):3401-3410.
18. Merino R, Rodriguez-Leon J, Macias D, Ganan Y, Economides AN, Hurle JM: The BMP antagonist Gremlin regulates outgrowth, chondrogenesis and programmed cell death in the developing limb. Development 1999, 126:5515-5522.
19. Hsu DR, Economides AN, Wang X, Eimon PM, Harland RM: The Xenopus dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities. Mol Cell 1998, 1:673-683.
20. Ichimura T, Isobe T, Okuyama T, Takahashi N, Araki K, Kuwano R, Takahashi Y: Molecular cloning of cDNA coding for brain-specific 14-3-3 protein, a protein kinase-dependent activator of tyrosine and tryptophan hydroxylases, Proc Natl Acad Sci USA 1988, 85:7084-7088.
21. Ichimura-Ohshima Y, Morii K, Ichimura T, Araki K, Takahashi Y, Isobe T, Minoshima S, Fukuyama R, Shimizu N, Kuwano R: cDNA cloning and chromosome assignment of the gene for human brain 14-3-3 protein eta chain. J Neurosci Res 1992, 31:600-605.
22. Ichimura T, Uchiyama J, Kunihiro O, Ito M, Horigome T, Omata S, Shinkai F, Kaji H, Isobe T: Identification of the site of interaction of the 14-3-3 protein with phosphorylated tryptophan hydroxylase. J Biol Chem 1995, 270:28515-28518.
23. Tommerup N, Leffers H: Assignment of the human genes encoding 14-3-3 Eta (YWHAH) to 22q12, 14-3-3 zeta (YWHAZ) to 2p25.1-p25.2, and 14-3-3 beta (YWHAB) to 20q13.1 by in situ hybridization. Genomics 1996, 33:149-150.
24. Vincenz C, Dixit VM: 14-3-3 proteins associate with A20 in an isoform-specific manner and function both as chaperone and adapter molecules. J Biol Chem 1996, 271:20029-20034.
25. Wakui H, Wright AP, Gustafsson J, Zilliacus J: Interaction of the ligand-activated glucocorticoid receptor with the 14-3-3 eta protein. J Biol Chem 1997, 272:8153-8156.
26. Toyooka K, Muratake T, Tanaka T, Igarashi S, Watanabe H, Takeuchi H, Hayashi S, Maeda M, Takahashi M, Tsuji S, Kumanishi T, Takahashi Y: 14-3-3 protein eta chain gene (YWHAH) polymorphism and its genetic association with schizophrenia. Am J Med Genet 1999, 88:164-167.
27. Yu T, Robb VA, Singh V, Gutmann DH, Newsham IF: The 4.1/ezrin/radixin/ moesin domain of the DAL-/Protein 4.1B tumour suppressor interacts with 14-3-3 proteins. Biochem J 2002, 365(PT 3):783-789.
28. Sato S, Fujita N, Tsuruo T: Regulation of kinase activity of 3-phosphoinositide-dependent protein kinase-1 by binding to 14-3-3. J Biol Chem 2002, 277:39360-39367.
29. Kim JW, Lee CG, Cho YH, Kim JH, Kim SJ, Kim HK, Park TC, Song SK, Namkoong SE: CUMC-6, a new diploid human cell line derived from a squamous carcinoma of the uterine cervix. Gynecol Oncol 1996, 62:230-240.
30. Liang P, Pardee AB: Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 1992, 257:967-971.
31. Opitz OG: Telomeres, telomerase and malignant transformation. Curr Mol Med 2005, 5(2):219-226.
32. Wai LK: Telomeres, telomerase, and tumorigenesis-a review. MedGenMed 2004, 6(3):19.
33. Topol LZ, Modi WS, Koochekpour S, Blair DG: Drm/Gremlin maps to human chromosome 15 and is highly expressed in adult and fetal brain. Cytogenet Cell Genet 2000, 89:79-84.
34. Wick W, Petersen I, Schmutzler RK. Wolfarth B, Lenartz D, Bierhoff E, Hummerich JI, Muller DJ, Stangl AP, Schramm J, Wiestler OD, von Deimling A: Evidence for a novel tumor suppressor gene on chromosome15 associated with progression to a metastatic stage in breast cancer. Oncogene 1996, 12:973-978.
35. Chen B, Blair DG, Plisov S, Vasiliev G, Perantoni AO, Chen Q, Athanasiou M, Wu JY, Oppenheim JJ, Yang D: Cutting edge: bone morphogenetic protein antagonists Drm/Gremlin and Dan interact with Slits and act as negative regulators of monocyte chemotaxis. J Immunol 2004, 173:5914-5917.
36. Suzuki M, Shigematsu H, Shames DS, Sunaga N, Takahashi T, Shivapurkar N, Iizasa T, Frenkel EP, Minna JD, Fujisawa T, Gazdar AF: DNA methylation-associated inactivation of TGFbeta-related genes DRM/ Gremlin,RUNX3, and HPP1 in human cancers. Br J Cancer 2005, 93:1029-1037.
37. Fu H, Subramanian RR, Masters SC: 14- 3-3 PROTEINS: Structure, function, and regulation. Annu Rey Pharmacol Toxicol 2000, 40:617-647.
38. Fanger GR, Widmann C, Porter AC, Sather S, Johnson GL, Vaillancourt RR: 14-3-3 proteins interact with specific MEK kinases. J Biol Chem 1998, 273:3476-3483.
39. Craparo A, Freund R, Gustafson TA: 14- 3-3 interacts with the insulin-like growth factor 1 receptor and insulin receptor substrate 1 in a phosphoserine-dependent manner. J Biol Chem 1997, 272:11663-11669.
40. Honda R, Ohba Y, Yasuda H: 14-3-3 protein binds to the carboxyl half of mouse weel kinase. Biochem Biophys Res Commun 1997, 230:262-265.
41. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ: Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X. Cell 1996, 87:619-628.
42. 2arrest in the Xenopus oocyte: a role for 14- 3-3-mediated inhibition of Cdc25 nuclear import. EMBO J 1999, 18:2174-2183.
43. Aitken A: 14-3-3 and its possible role in co-ordinating multiple signaling pathway. Trends Cell Bial 1996, 6:341-347.
44. Roy S, McPherson RA, Apolloni A, Yan J, Lane A, Clyde-Smith J, Hancock JF: 14-3-3 facilitates Ras-dependent Raf-1 activation in vitro and in vivo. Mol Cell Biol 1998, 18:3947-3955.
45. Kosaki A, Yamada K, Suga J, Otaka A, Kuzuya H: 14-3-3 protein associates with insulin receptor substrate 1 and decreases insulin-stimulated phosphatidylinositol 3-kinase activity in 3T3L1 adipocytes. J Biol Chem 1998, 273:940-944.
46. Braselmann S, McCormick F: Bcr and Raf form a complex in vivo via 14-3-3 proteins. EMBO J 1995, 14:4839-4848.
47. van Heusden GP: 14-3-3 proteins: regulators of numerous eukaryotic proteins. IUBMB Life 2005, 57:623-629.